Table 3a.
Model | ||||
---|---|---|---|---|
Parameter | Null | Proteinuria only | FGF23 only | Proteinuria and FGF23 |
Fixed effect level | ||||
Constant (Proteinuria= 0.45, FGF23= 110) | 4.113 ± 0.029 | 4.117 ± 0.027 | 4.14 ± 0.025 | 4.138 ± 0.024 |
log2(Proteinuria/0.45) | 0 | −0.074 ± 0.014 | 0 | −0.039 ± 0.013 |
log2(FGF23 / 110) | 0 | 0 | −0.219 ± 0.026 | −0.187 ± 0.027 |
Fixed effect slope (years from baseline) | ||||
Constant (Proteinuria= 0.45, FGF23= 110) | −0.087 ± 0.010 | −0.082 ± 0.009 | −0.082 ± 0.010 | −0.080 ± 0.009 |
log2(Proteinuria/0.45) | 0 | −0.033 ± 0.005 | 0 | −0.029 ± 0.005 |
log2(FGF23 / 110) | 0 | 0 | −0.044 ± 0.011 | −0.022 ± 0.010 |
Random effects | ||||
S.D. (level) [σ1] | 0.379 | 0.349 | 0.316 | 0.308 |
S.D. (slope) [σ2] | 0.111 | 0.084 | 0.103 | 0.082 |
Correlation [] | 0.377 | 0.262 | 0.221 | 0.173 |
S.D. residual [σ] | 0.139 | 0.141 | 0.139 | 0.141 |
AIC | 91.109 | 39.553 | 32.108 | 5.383 |
Bold indicates p<0.05 for fixed effects. Estimates ± Standard errors. Corresponding 95% confidence intervals may be calculated as ± 1.96 × Standard errors.
Abbreviations: S.D., standard deviation; SBP z-score, systolic blood pressure z-scores based on the normal population adjusted for age, gender and height; FGF23, fibroblast growth factor 23; AIC, Akaike’s information criterion